Welcome to our dedicated page for Blackrock news (Ticker: BLK), a resource for investors and traders seeking the latest updates and insights on Blackrock stock.
BlackRock, Inc. reports developments from a global asset management and financial technology business built around investment products, institutional client services and technology platforms. Recurring updates include operating results, net flows across ETFs, active strategies and private markets, and product launches under the iShares brand, including fixed income ETFs tied to leveraged loans and other credit markets.
Company news also covers Aladdin and Preqin data, analytics and benchmark capabilities for private credit, infrastructure-focused activity through Global Infrastructure Partners, and philanthropic workforce initiatives funded by The BlackRock Foundation. These releases connect BlackRock's asset management platform with technology services, private markets data, infrastructure investment themes and skilled-trades workforce programs.
BlackRock Long Term Private Capital has agreed to acquire a majority interest in Paradigm Oral Health from InTandem Capital Partners. Paradigm, founded in 2018, focuses on providing quality oral health care and dental implant surgery, partnering with elite surgeons across the U.S. to enhance patient care. With over 100 surgeons and 75 facilities, Paradigm utilizes advanced practice management technology, Paragon, for improved performance. This acquisition represents BlackRock's sixth investment, signaling strong growth prospects for Paradigm.
The iShares S&P GSCI Commodity-Indexed Trust (GSG) announced the availability of its 2021 Schedule K-3 forms for shareholders, detailing international tax relevance. This information is crucial for non-U.S. shareholders and those needing foreign tax credit details. Shareholders can access the forms online at www.taxpackagesupport.com/iSharesGSG. BlackRock, as the trust's fiduciary, aims to enhance financial well-being and offers a robust suite of ETFs with over $2.78 trillion in assets. For electronic copies, shareholders can contact Tax Package Support at (866) 792-0048.
BlackRock Corporate High Yield Fund (NYSE: HYT) announced a rights offering, allowing shareholders as of September 20, 2022, to purchase additional shares at a discount. The Fund's Board approved this move to increase assets for investment opportunities, aiming to benefit shareholders through current income and potential capital appreciation. The Offer includes opportunities in the high yield market, enhanced liquidity, and reduced expense ratios, with the Advisor covering all Offer expenses. The subscription price will be determined on the expiration date of the Offer, expected October 13, 2022.
The Board of Directors of BlackRock Corporate High Yield Fund, Inc. (HYT) declared an early monthly distribution for October 2022 of $0.077900 per share. Shares purchased after October 3, 2022, will not receive this distribution. Key dates noted are: Declaration on 9/8/2022, Ex-Date on 10/4/2022, Record Date on 10/5/2022, and Payable Date on 10/31/2022. The Fund follows a managed distribution plan, aiming to distribute all available income while adhering to IRS regulations.
In uncertain markets, endowments, foundations, and healthcare investors are increasing private equity allocations.
53% of non-profit institutional investors are raising allocations to private equity to seek returns amid volatile markets. Key risks identified include inflation and rising interest rates, with interests shifting towards real estate, public equities, and natural resources. Despite concerns over potential losses, nearly half of investors are focused on generating unique returns, with over 75% favoring private equity. The survey indicates growing adoption of ESG standards in investment practices.
BlackRock has launched the BlackRock Future Financial and Technology ETF (NYSE Arca: BPAY), enhancing its Megatrends platform. The actively managed fund focuses on firms driving innovation in financial services, with a specific aim of maximizing total returns. Lead Portfolio Manager Vasco Moreno noted a 30% increase in fintech usage during the pandemic in the U.S. BPAY is the sixth active ETF in BlackRock's U.S. Megatrends platform, boasting a 0.70% expense ratio. BlackRock manages over $50 billion in AUM across 44 thematic products.
BlackRock's iShares MSCI Russia ETF (ERUS) announced the suspension of share redemption rights effective August 3, 2022, following SEC directives to facilitate portfolio liquidation. BlackRock will commence this liquidation process on August 17, 2022, distributing assets to shareholders, subject to a reserve for transaction costs. Due to sanctions from the Ukraine conflict, liquidation may take time, extending fund existence to at least December 31, 2023. Future updates on the fund's status will be available on the product’s webpage.
BlackRock has launched its first Model Portfolios for Women, addressing unique factors affecting women's investing success: life expectancy, income gaps, and employment gaps. Women in the U.S. outlive men by over five years and earn approximately $0.82 for every $1 earned by men, with larger gaps for Black and Latina women. These portfolios aim to enhance equity allocation across women's long investment horizons. This initiative reflects BlackRock’s commitment to advancing gender equity and supports women in achieving better long-term financial outcomes.
According to BlackRock’s latest retirement survey, 37% of Americans feel unprepared for retirement, a notable increase attributed to inflation and market volatility. Confidence among workplace savers has declined from 68% in 2021 to 51%. Inflation raises concerns for 87% of these savers, with 64% fearing their savings won't last a lifetime. However, Gen Z stands out, saving an average of 14% of their earnings, the highest among generations. The survey reveals a growing interest in guaranteed income options, with 87% of workplace savers willing to invest for regular payments.
BlackRock and QLS Advisors have partnered to create data-driven investment solutions aimed at accelerating biomedical innovation. By leveraging BlackRock's investment platform and QLS's advanced technologies for evaluating clinical trial success, this collaboration aims to direct funding to promising therapeutic developments in public and private companies. With a Scientific Advisory Council of industry leaders, the initiative seeks to improve capital allocation in healthcare while generating attractive returns for clients.